{
    "2020-06-03": [
        [
            {
                "time": "2020-03-18",
                "original_text": "How Are Biotech ETFs Reacting to Coronavirus Treatment News?",
                "features": {
                    "keywords": [
                        "biotech",
                        "ETFs",
                        "coronavirus",
                        "treatment"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-10",
                "original_text": "Wednesday Morning Market Highlights",
                "features": {
                    "keywords": [
                        "market",
                        "highlights"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-07-22",
                "original_text": "Bristol Myers' Zeposia Meet Goals in Ulcerative Colitis Study",
                "features": {
                    "keywords": [
                        "Bristol Myers",
                        "Zeposia",
                        "ulcerative colitis",
                        "study"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08-15",
                "original_text": "Why These 5 Pharma Stocks Are Outplaying 90% Of The Stock Market",
                "features": {
                    "keywords": [
                        "pharma",
                        "stocks",
                        "outperform"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05-07",
                "original_text": "HealthEquity (HQY) Q1 Earnings and Revenues Miss Estimates",
                "features": {
                    "keywords": [
                        "HealthEquity",
                        "earnings",
                        "revenues",
                        "miss estimates"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-06-05",
                "original_text": "EULAR 2020: Lilly Shares New Data for Olumiant® in Rheumatoid Arthritis and Systemic Lupus Erythematosus",
                "features": {
                    "keywords": [
                        "EULAR",
                        "Lilly",
                        "Olumiant",
                        "rheumatoid arthritis",
                        "systemic lupus erythematosus"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-06",
                "original_text": "EULAR 2020: Lilly's Taltz® (ixekizumab) Continues to Show Robust and Consistent Efficacy in Psoriatic Arthritis",
                "features": {
                    "keywords": [
                        "EULAR",
                        "Lilly",
                        "Taltz",
                        "psoriatic arthritis",
                        "efficacy"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-27",
                "original_text": "Eli Lilly Leaps Past Regeneron's COVID-19 Treatment Candidate",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Regeneron",
                        "COVID-19",
                        "treatment"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}